CRYOPORT, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CRYOPORT, INC. (CYRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.09 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 18.67K shares, a 8.26% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 187.42K shares, a 33.84% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 304.77K shares, a 80.76% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 17.25K shares.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 0.00 shares.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 0.00 shares.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 4.06M shares, a 802.91% increase from fiscal 2012.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 450.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.09M shares 10-Q · filed 2026-08-06 | |||
| 2025-09-30 | 18.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 206.09K shares derived: sum of 2 quarters · filed 2025-11-06 | 510.86K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 187.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 492.19K shares 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | 304.77K shares 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | 17.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 157.28K shares derived: sum of 2 quarters · filed 2024-11-07 | 325.89K shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 140.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 308.64K shares 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 168.61K shares 10-Q · filed 2024-05-08 | |||
| 2023-09-30 | 394.05K shares 10-Q · filed 2023-11-09 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2023-02-28 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-02-28 | |||
| 2013-12-31 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | 295.98K shares derived: sum of 2 quarters · filed 2014-02-13 | 7.65M shares 10-Q · filed 2014-02-13 | 7.77M shares derived: sum of 4 quarters · filed 2014-02-13 |
| 2013-09-30 | 270.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | 7.62M shares 10-Q · filed 2013-11-18 | 7.75M shares derived: sum of 3 quarters · filed 2013-11-18 | 10.12M shares derived: sum of 4 quarters · filed 2013-11-18 |
| 2013-06-30 | 7.35M shares 10-Q · filed 2013-08-14 | 7.48M shares derived: sum of 2 quarters · filed 2013-08-14 | 9.85M shares derived: sum of 3 quarters · filed 2013-08-14 | 10.80M shares derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | 123.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | 2.50M shares derived: sum of 2 quarters · filed 2013-06-25 | 3.45M shares derived: sum of 3 quarters · filed 2013-06-25 | 4.06M shares 10-K · filed 2013-06-25 |
| 2012-12-31 | 2.38M shares 10-Q · filed 2013-02-14 | 3.33M shares derived: sum of 2 quarters · filed 2013-02-14 | 3.94M shares 10-Q · filed 2014-02-13 | 3.94M shares derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-09-30 | 950.00K shares 10-Q · filed 2012-11-09 | 1.56M shares 10-Q · filed 2013-11-18 | 1.56M shares derived: sum of 3 quarters · filed 2013-08-14 | 1.58M shares derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-06-30 | 614.79K shares 10-Q · filed 2013-08-14 | 614.79K shares derived: sum of 2 quarters · filed 2013-08-14 | 629.79K shares derived: sum of 3 quarters · filed 2013-08-14 | 664.79K shares derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | 15.00K shares derived: sum of 2 quarters · filed 2013-06-25 | 50.00K shares derived: sum of 3 quarters · filed 2013-06-25 | 450.00K shares 10-K · filed 2013-06-25 |
| 2011-12-31 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | 50.00K shares derived: sum of 2 quarters · filed 2013-02-14 | 450.00K shares 10-Q · filed 2013-02-14 | |
| 2011-09-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | 435.00K shares 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | 400.00K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |